What does the newborn BCG vaccine prevent?
The BCG vaccine for newborns is primarily used to prevent tuberculosis, and it can also help prevent common colds in children. Additionally, clinically, the BCG vaccine may be used to treat asthmatic bronchitis and serve as an adjunctive therapy for tumors.
After birth, newborns have relatively weak immune systems. It is recommended to administer the BCG vaccine within 24 to 48 hours after birth to stimulate the body's production of effective antibodies, enhance immune resistance, and prevent the occurrence of tuberculosis. After vaccination, local redness and swelling may occur, which is a normal reaction. A scab typically forms 8 to 12 weeks after vaccination. If pus develops, small ulcers form, or lymph nodes under the arm become swollen, it is important to maintain cleanliness and hygiene of the affected area. Do not incise or drain the site; instead, seek active treatment under a doctor’s guidance to prevent the spread of infection.
The BCG vaccine should not be administered immediately after birth if the newborn is premature, weighs less than 2.5 kg, or has conditions such as pathological jaundice, neonatal pneumonia, or neonatal sepsis.